{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:17:18Z","timestamp":1770959838311,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1007\/bf02353408","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T18:25:52Z","timestamp":1144347952000},"page":"19-40","source":"Crossref","is-referenced-by-count":17,"title":["Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma"],"prefix":"10.1007","volume":"22","author":[{"given":"Joseph C.","family":"Ojingwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Spahn-Langguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie Z.","family":"Benet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1994,2,1]]},"reference":[{"key":"BF02353408_CR1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2165\/00003088-198712060-00002","volume":"12","author":"J. H. Lin","year":"1987","unstructured":"J. H. Lin, D. M. Cocchetto, and D. E. Duggan. Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.Clin. Pharmacokin. 12:402\u2013432 (1987).","journal-title":"Clin. Pharmacokin."},{"key":"BF02353408_CR2","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/0006-2952(79)90120-5","volume":"28","author":"G. B. Wong","year":"1979","unstructured":"G. B. Wong and E. M. Sellers. Intravascular factors affecting diazepam binding to human serum albumin.Biochem. Pharmacol. 28:3265\u20133270 (1979).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353408_CR3","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/jps.2600631103","volume":"63","author":"P. H. Hinderling","year":"1974","unstructured":"P. H. Hinderling, J. Bres, and E. R. Garrett. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.J. Pharm. Sci. 63: 1684\u20131689 (1974).","journal-title":"J. Pharm. Sci."},{"key":"BF02353408_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03602539208996289","volume":"24","author":"H. Spahn-Langguth","year":"1992","unstructured":"H. Spahn-Langguth and L. Z. Benet. Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism?Drug Metab. Rev. 24:5\u201348 (1992).","journal-title":"Drug Metab. Rev."},{"key":"BF02353408_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4684-5134-4_42","volume":"197","author":"H. W. Ruelius","year":"1986","unstructured":"H. W. Ruelius, S. K. Kirkham, E. M. Young, and F. W. Janssen. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin.Adv. Exp. Med. Biol. 197:431\u2013444 (1986).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BF02353408_CR6","first-page":"1052","volume":"12","author":"G. Sudlow","year":"1976","unstructured":"G. Sudlow, D. J. Birkett and D. N. Wade. Further characterization of specific drug binding sites on human serum albumin.Mol. Pharmacol. 12:1052\u20131061 (1976).","journal-title":"Mol. Pharmacol."},{"key":"BF02353408_CR7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3109\/00498258709044004","volume":"17","author":"D. S. Wells","year":"1987","unstructured":"D. S. Wells, F. W. Janssen, and H. W. Ruelius. Interactions between oxaprozin glucuronide and albumin.Xenobiotica 17:1437\u20131449 (1987).","journal-title":"Xenobiotica"},{"key":"BF02353408_CR8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/0006-2952(85)90404-6","volume":"34","author":"F. D. Boudinot","year":"1985","unstructured":"F. D. Boudinot, C. A. Homon, W. J. Jusko, and H. W. Ruelius. Protein binding of oxazepam and its glucuronide conjugates to human serum albumin.Biochem. Pharmacol. 34: 2115\u20132121 (1985).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353408_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-2952(92)90012-8","volume":"44","author":"P. J. Hayball","year":"1992","unstructured":"P. J. Hayball, R. L. Nation, and F. Bochner. Steroselective interactions of ketoprofen glucuronides with human plasma protein and serum albumin.Biochem. Pharmacol. 44:291\u2013299 (1992).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353408_CR10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0006-2952(90)90212-4","volume":"39","author":"S. Iwakawa","year":"1990","unstructured":"S. Iwakawa, H. Spahn, L. Z. Benet, and E. T. Lin. Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin.Biochem. Pharmacol. 39:949\u2013953 (1990).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353408_CR11","first-page":"449","volume":"183","author":"A. Rubin","year":"1972","unstructured":"A. Rubin, P. Warrick, R. L. Wolen, S. M. Chernish, A. S. Ridolfo, and C. M. Gruber. Physiological disposition of fenoprofen in man. III. Metabolism and protein binding of fenoprofen.J. Pharmacol. Exp. Ther. 183:449\u2013457 (1972).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02353408_CR12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0006-2952(81)90151-9","volume":"30","author":"K. J. Fehske","year":"1981","unstructured":"K. J. Fehske, W. E. M\u00fcller, and U. Woller. The location of drug binding sites in human serum albumin.Biochem. Pharmacol. 30:687\u2013692 (1981).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353408_CR13","first-page":"1507","volume":"31","author":"U. Busch","year":"1981","unstructured":"U. Busch, M. Molzahn, G. Bozler, and F. W. Koss. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.Arzneim. Forsch. 31:1507 (1981).","journal-title":"Arzneim. Forsch."},{"key":"BF02353408_CR14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/clpt.1981.241","volume":"30","author":"T. G. Murray","year":"1981","unstructured":"T. G. Murray, S. T. Chiang, H. H. Koepke, and B. R. Walker. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.Clin. Pharmacol. Ther. 30:805\u2013816 (1981).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cpt1976192224","volume":"19","author":"W. A. Cressman","year":"1976","unstructured":"W. A. Cressman, G. F. Wortham, and J. Plostnieks. Absorption and excretion of tolmetin in man.Clin. Pharmacol. Ther. 19:224\u2013233 (1976).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cpt1979261122","volume":"26","author":"J. M. Grindel","year":"1979","unstructured":"J. M. Grindel, B. H. Migdalof, and J. Plostnieks Absorption and excretion of tolmetin in arthritic patients.Clin. Pharmacol. Ther. 26:122\u2013128 (1979).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/13.3.132","volume":"13","author":"E. C. Huskisson","year":"1974","unstructured":"E. C. Huskisson, H. Berry, J. Scott, and W. H. Balme. Tolectin for rheumatoid arthritis.Rheumatol. Rehabil. 13:132\u2013134 (1974).","journal-title":"Rheumatol. Rehabil."},{"key":"BF02353408_CR18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cpt1975175599","volume":"17","author":"M. L. Selley","year":"1975","unstructured":"M. L. Selley, J. Glass, E. J. Triggs, and J. Thomas. Pharmacokinetic studies of tolmetin in man.Clin. Pharmacol. Ther. 17:599\u2013605 (1975).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1015823206607","volume":"7","author":"A. Munafo","year":"1990","unstructured":"A. Munafo, A. F. McDonagh, P. C. Smith, and L. Z. Benet. Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.Pharm. Res. 7:21\u201327 (1990).","journal-title":"Pharm. Res."},{"key":"BF02353408_CR20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jps.2600700733","volume":"70","author":"P. J. O'Neill","year":"1981","unstructured":"P. J. O'Neill. Plasma protein binding of zomepirac sodium.J Pharm. Sci. 70:818\u2013819 (1981).","journal-title":"J Pharm. Sci."},{"key":"BF02353408_CR21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1172\/JCI112392","volume":"77","author":"P. C. Smith","year":"1986","unstructured":"P. C. Smith, A. F. McDonagh, and L. Z. Benet. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.J. Clin. Invest. 77:934\u2013939 (1986).","journal-title":"J. Clin. Invest."},{"key":"BF02353408_CR22","first-page":"503","volume":"14","author":"P. C. Smith","year":"1986","unstructured":"P. C. Smith and L. Z. Benet Characterization of the isomeric esters of zomepirac glucuronide by proton NMR.Drug Metab. Dispos. 14:503\u2013505 (1986).","journal-title":"Drug Metab. Dispos."},{"key":"BF02353408_CR23","first-page":"110","volume":"13","author":"P. C. Smith","year":"1985","unstructured":"P. C. Smith, J. Hasegawa, and L. Z. Benet. Stability of acylglucuronides in blood, plasma and urine. Studies with zomepirac.Drug Metab. Dispos. 13:110\u2013112 (1985).","journal-title":"Drug Metab. Dispos."},{"key":"BF02353408_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/clpt.1988.120","volume":"44","author":"M. L. Hyneck","year":"1988","unstructured":"M. L. Hyneck, P. C. Smith, A. Munafo, A. F. McDonagh, and L. Z. Benet. Disposition and irreversible plasma protein binding of tolmetin in humans.Clin. Pharmacol. Ther. 44:107\u2013114 (1988).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/clpt.1985.146","volume":"38","author":"P. C. Smith","year":"1985","unstructured":"P. C. Smith, P. N. J. Langendijk, J. A. Bosso, and L. Z. Benet. Effect of probenecid on the formation and elimination of acyl glucuronides.Clin. Pharmacol. Ther. 38:121\u2013127 (1985).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353408_CR26","first-page":"102","volume":"1","author":"A. Goldstein","year":"1949","unstructured":"A. Goldstein. The interactions of drugs and plasma proteins.Pharmacol. Rev. 1:102\u2013165 (1949).","journal-title":"Pharmacol. Rev."},{"key":"BF02353408_CR27","first-page":"283","volume":"3","author":"D. D. Summer","year":"1975","unstructured":"D. D. Summer, P. G. Dayton, S. A. Cucinell, and J. Plostnieks, Metabolism of tolmetin in rat, monkey, and man.Drug Metab. Dispos. 3:283\u2013286 (1975).","journal-title":"Drug Metab. Dispos."},{"key":"BF02353408_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0003-2697(72)90172-8","volume":"48","author":"S. Keresztes-Nagy","year":"1972","unstructured":"S. Keresztes-Nagy, R. F. Mais, Y. T. Oester, and J. F. Zarolinsky. Protein binding methodology: Comparison of equilibrium dialysis and frontal analysis chromatography in the study of salicylate binding.Anal. Biochem. 48:80\u201389 (1972).","journal-title":"Anal. Biochem."},{"key":"BF02353408_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000136516","volume":"12","author":"R. W. Mason","year":"1974","unstructured":"R. W. Mason and E. G. McQueen. Protein binding of indomethacin: Binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate in vitro.Pharmacology 12:12\u201319 (1974).","journal-title":"Pharmacology"},{"key":"BF02353408_CR30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/00498257309151547","volume":"3","author":"R. F. W. Mills","year":"1973","unstructured":"R. F. W. Mills, S. S. Adams, E. E. Cliffe, W. Dickinson, and J. S. Nicholson. The metabolism of ibuporofen.Xenobiotica 3:589\u2013598 (1973).","journal-title":"Xenobiotica"},{"key":"BF02353408_CR31","first-page":"36","volume-title":"Drug-Protein Binding","author":"I. Sj\u00f6holm","year":"1986","unstructured":"I. Sj\u00f6holm. The specificity of drug binding sites on human serum albumin. In M. M. Reidenberg and S. Erill (eds.),Drug-Protein Binding, Praeger, New York, 1986, pp. 36\u201345."},{"key":"BF02353408_CR32","series-title":"Symposia Medica Hoechst","first-page":"1","volume-title":"Protein Binding and Drug Transport","author":"D. J. Burkett","year":"1985","unstructured":"D. J. Burkett and S. Wanwimalruk. Albumin as a specific binding protein for drugs and endogenous compounds. In J.-P. Tillement and E. Lindenlaub (eds.),Protein Binding and Drug Transport, Symposia Medica Hoechst, Schattauer Verlag, New York, 1985, pp. 1\u201347."},{"key":"BF02353408_CR33","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/0006-2952(91)90233-U","volume":"42","author":"R. G. Dickinson","year":"1991","unstructured":"R. G. Dickinson and A. R. King. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro.Biochem. Pharmacol. 42:2301\u20132306 (1991).","journal-title":"Biochem. Pharmacol."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02353408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02353408\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02353408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T10:31:43Z","timestamp":1558089103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02353408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["BF02353408"],"URL":"https:\/\/doi.org\/10.1007\/bf02353408","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}